The overall objectives are to demonstrate at least in one disease (diabetes), that stem cell-based cell replacement therapy is effective and safe, to provide therapeutic candidates for stroke and hematological diseases, and to build a strong base of knowledge about stem cells and disease mechanisms to pave the way for future efforts to devise new clinically effective treatments.
Stefan Scheding's group co-authors a new paper published in Cell Reports (Cell Press): "Self-Renewing Human Bone Marrow Mesenspheres Promote Hematopoietic Stem Cell Expansion". This paper describes a promissing method to expand transplantable hematopoietic stem cells by co-culture with mesenchymal bone marrow stem cells grown as non-adherent mesenspheres.
You are all welcome to Stem Therapy Seminar Series with Professor Atsuchi Iwama Department of Cellular and Molecular Medicine Chiba University, Japan. Title: “Role of polycomb proteins in hematopoietic stem cells and myeloid malignancies”
Wednesday 8 of May, 2013, 15:00-16:00 Segerfalksalen, WNC, Visiting address: Sölvegatan 17, Lund.